On its own, Trump admin's price disclosure policy unlikely to help curb drug prices
The Trump administration's proposal to require pharmaceutical companies to publish drug prices in TV ads is unlikely to help control drug prices, according to a study publishing Jan. 22 in JAMA Internal Medicine.
Jan 22, 2019
0
2